Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal Cancer

B. Gruenberger(Medical University of Vienna), Thomas Gruenberger(Sigmund Freud Privatuniversität Wien)

Journal of Clinical Oncology

April 8, 2008

10.1200/jco.2007.13.7679

Cited by 425

Related Papers

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial

|The Lancet|2008|1.9k

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

|The Lancet Oncology|2009|960

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

|Annals of Oncology|2010|80